2013 Annual Meeting Abstracts
The Northern New England Clinical Oncology Society seeks abstracts on hematology/oncology topics to share knowledge during the Annual Meeting. Physicians, nurses, mid-level providers, ancillary health care providers (psychologists, physical therapists, etc.), administrators, pharmacists, and post-graduate trainees (fellows, residents) are eligible to submit abstracts. Abstracts previously submitted to ASCO, ASH, etc. are acceptable. Limited funding through travel and expense grants will be available. NNECOS reserves the right to review and accept submissions.

Poster Presentation

Authors of accepted abstracts will be invited to attend the poster session on the evening of Friday October 25, 2013, offered a discounted meeting registration of $35.00, and are eligible to apply for a travel and expense grant.

Podium Presentation

Three abstracts will be selected for oral presentations on Saturday October 26, 2013. The responsible first author will have travel, registration, and lodging covered by NNECOS.

Selected Areas/Topics may include:

  • Novel Clinical Trials/Interventions
  • Nursing Care
  • Palliative Care
  • Business/Administrative issues
  • Pilot Studies
  • Best Clinical Practices
  • Patient and Survivor Issues

Abstracts Guidelines:

  • 250 words or less, 10-12 point font
  • Affiliations clearly listed
  • Submitted electronically via nnecos website
  • First authors will receive e-mail verification of receipt.

 Submission Deadline:   Saturday, August 31, 2013 at 5pm

Contact Information

Your name, institution, address, telephone number, fax number, and e­mail address. As the First Author (presenter), you will receive all future correspondence from NNECOS.

Abstract Title

The title of your abstract in sentence case, capitalizing only the first letter of the first word of the title and any proper nouns or acronyms. Do not use proprietary drug names in the title; use generic drug names instead. Do not refer to study results or conclusions in the title; it should objectively describe the study.  NNECOS reserves the right to edit abstract titles to conform to this policy.

Coauthor(s)

The name and institution of each coauthor.

Disclosure Declaration

A separate disclosure form should be filled out by the first author and by each co-authors. Please fax to 603-887-6049 after submission.

RESPONSIBILITIES OF THE FIRST AUTHOR

The First Author must

  • Verify that all coauthors are aware of the contents of the abstract and support its data.
  • Agree, on behalf of all coauthors, to transfer copyright to NNECOS for publication in the annual meeting proceedings and on the NNECOS website.
  • Agree to deliver an oral presentation if selected (first authors may indicate desire to be considered for poster presentation only)
  • Agree to be present during the scheduled time of a Poster Session
  • Adhere to the following conflict of interest policy

CONFLICT OF INTEREST POLICY 

NNECOS must ensure fair balance, independence, objectivity, and scientific rigor in all of its educational activities through appropriate disclosure of financial interests, among other things. The following interests or relationships must be disclosed: employment or leadership position, advisory role, stock ownership, honoraria, research funding, expert testimony, and other remuneration. It is the responsibility of the First Author to obtain disclosure information from all coauthors and to provide all disclosure of such interests and relationships at the time of submission.
 
 

Northern New England Clinical Oncology Society
P.O. Box 643
Sandown, NH 03873-0643
Telephone (603) 887-1948
info@nnecos.org

This website brought to you by:


Powered by Wild Apricot Membership Software